H2BC9 and H2BC11 positively correlate with the immune checkpoint PDCD1, which mediates inhibitory pathways that are exploited by tumors to mitigate antitumor immunity and escape destruction by the immune system, thereby promoting tumor survival (58). The gene discussed is H2BC11; the disease is neoplasm.